[EN] TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF BREAST CANCER<br/>[FR] COMPOSÉS D'ALCÈNE TÉTRASUBSTITUÉS ET LEUR UTILISATION POUR LE TRAITEMENT DU CANCER DU SEIN
申请人:EISAI R&D MAN CO LTD
公开号:WO2018098305A1
公开(公告)日:2018-05-31
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.